The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration: An in vitro study of levofloxacin

International Journal of Antimicrobial Agents

Volumn 24, Issue 5, 2004, Pages 468-472

  Choi, Gordon ^a   Gomersall, Charles D ^a   Lipman, Jeff ^a,b   Wong, April ^a   Joynt, Gavin M ^a   Leung, Patricia ^a   Ramsay, Sarah J ^a   Ho, Oi Man ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anti bacterial agents; Kidney failure; Pharmacokinetics; Quinolones; Renal replacement therapy

Indexed keywords

LEVOFLOXACIN; POLYACRYLONITRILE;

ARTICLE; DILUTION; DRUG ADSORPTION; DRUG ELIMINATION; FILTER; HEMOFILTRATION; PRIORITY JOURNAL;

HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; MEMBRANES, ARTIFICIAL; OFLOXACIN; RENAL REPLACEMENT THERAPY;

EID: 7044263237     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.06.005     Document Type: Article

References (24)

1. M. Pinder, R. Bellomo, and J. Lipman Pharmacological principles of antibiotic prescription in the critically ill Anaesth Intensive Care 30 2002 134 144
2. S.L. Preston, G.L. Drusano, and A.L. Berman Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials J. Am. Med. Assoc. 279 1998 125 129
3. J.J. Schentag Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models Clin. Infect. Dis. 31 Suppl 2 2000 S40 S44
4. W.A. Craig Pharmacokinetic/pharmacodynamic parameters: rationale for antimicrobial dosing of mice and men Clin Infect Dis. 26 1998 1 12
5. J.F. Bugge Pharmacokinetics and drug dosing adjustments during continuous veno-venous haemofiltration or haemodiafiltration in critically ill patients Acta Anaesthesiol Scand. 45 2001 929 934
6. E. Hansen, M. Bucher, and W. Jakob Pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration Intensive Care Med. 27 2001 371 375
7. F. Traunmüller, R. Thalhammer-Scherrer, and G.J. Locker Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients J Antimicrob Chemother. 47 2001 229 231
8. J. Böhler, J. Donauer, and F. Keller Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage Kidney Int. 56 Suppl 72 1999 S24 S28
9. S. Böttcher, H.V. Baum, and T. Hoppy-Tichy An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum J. Pharm. Biomed. Anal. 25 2004 197 203
10. M.J. Campbell, S.A. Julious, and D.G. Altman Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons Br. Med. J. 311 1995 1145 1148
11. E. Hansen, M. Bucher, and W. Jakob Pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration Intensive Care Med. 27 2001 371 375
12. F. Traunmüller, R. Thalhammer-Scherrer, and G.J. Locker Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients J. Antimicrob. Chemother. 47 2001 229 231
13. S.G. Guenter, H. Iven, and C. Boos Pharmacokinetics of levofloxacin during continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration in critically ill patients Pharmacotherapy 22 2002 175 183
14. J.A. Rebuck, D.N. Fish, and E. Abraham Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit Pharmacotherapy 22 2002 1216 1225
15. F.H. Yap, G.M. Joynt, and T.A. Buckley Association of serum albumin concentration and mortality risk in critically ill patients Anaesth Intensive Care 30 2002 202 207
16. E. Bergogne-Bérézin Clinical role of protein binding of quinolones Clin. Pharmacokinet. 41 2003 741 750
17. C. Ronco, and R. Bellomo Principles of solute clearance during continuous renal replacement therapy 1998 Kluwer Academic Publishers Dordrecht
18. S. Uchino, L. Cole, and H. Morimatsu Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution Intensive Care Med. 28 2002 1664 1667
19. S. Uchino, N. Fealy, and I. Baldwin Continuous veno-venous haemofiltration without anticoagulation. Am. Soc. Artif. Intern. Organs J. 50 2004 76 80
20. J. Böhler, J. Donauer, and F. Keller Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage Kidney Int. 56 Suppl 72 1999 S24 S28
21. C.A. Oborne, G. Buckton, and N. Barber The interaction of albumin and drugs with two haemofiltration membranes J. Clin. Pharm. Ther. 19 1994 119 125
22. N.O. Kronfol, A.H. Lau, and M.M. Barakat Aminoglycoside binding to polyacrylonitrile haemofilter membranes during continuous haemofiltration Trans. Am. Soc. Artif. Intern. Organs 33 1987 300 387
23. K.A. Rodvold, and M. Neuhauser Pharmacokinetics and pharmacodynamics of fluoroquinolones Pharmacotherapy 21 2004 233S 252S
24. G.J. Phillips, J.G. Davies, and C.J. Olliff Use of in vitro models of haemofiltration and haemodiafiltration to estimate dosage regimens for critically ill patients prescribed cefpirome J. Clin. Pharm. Ther. 23 1998 353 359